Sigma-Tau Finanziaria S.p.A. to Study a Possible Sale of Stake After Founder's Death
8/26/2011 8:31:32 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) and Sigma-Tau Finanziaria S.p.A. Announce Final Data From Clinical Trial of ZADAXIN as H1N1 Vaccine Enhancer
6/30/2010 9:24:13 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Hepatitis C Drug Fails Main Goal
11/5/2008 6:24:22 AM
More...
|
Anesiva, Inc. (ANSV) and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries
2/12/2008 8:41:39 AM
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) And Sigma-Tau Announce Positive Interim Survival Data From Large Phase 2 Malignant Melanoma Trial
12/22/2006 9:50:07 AM
More...
|
BurnsAdler Pharmaceuticals, Inc. Partners With Sigma-Tau Finanziaria S.p.A.
2/1/2006 10:57:39 PM
More...
|
Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) To Retire 8% Debentures Following Restructuring Of Dividends Payable On Series B Preferred Shares
10/19/2005 5:13:11 PM
More...
|
Reliant Pharmaceuticals, Inc. And Pronova Biocare Announce FDA Approval Of Omacor(R)
10/19/2005 5:12:17 PM
More...
|
BioDelivery Sciences International (BDSI) Announces Proposed Licensing Agreement With Sigma-Tau S.p.A.
10/19/2005 5:11:27 PM
More...
|
BioDelivery Sciences International (BDSI) Announces Proposed Licensing Agreement With Sigma-Tau S.p.A.
10/19/2005 5:11:27 PM
More...
|
|